Back to search
FDAFDA · Food and drugs·Recall number Z-0624-2024

SEROLOGY ToRCH lgM 2022 POSITIVE CONTROLI Intended for use with in vitro assays for determination of IgM antibodies to Cytomegalovirus (CMV), IgM antibodies to Rubella Virus, IgM antibodies to Toxoplasma gondii, IgM antibodies to Herpes Simplex Virus Type 1 and 2. Catalog Number: SR10349

Published January 10, 2024 · Recall initiated: November 6, 2023

Summary

FDA records medical device Class III recall Z-0624-2024, published January 10, 2024 and initiated November 6, 2023. Recalling firm: Randox Laboratories Ltd.; Status: Ongoing; Reported quantity: 1 unit; Lot: GTIN: 05055273216424 Bath/Lot Number: 157SR. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A decrease in the reactivity of HSV Type 1/2 lgM in the Serology ToRCH lgM Positive Control when tested on the DiaSorin Liaison XL.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Randox Laboratories Ltd.
Distributor
NY, WV
Lot
GTIN: 05055273216424 Bath/Lot Number: 157SR
Risk classification
Class III
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was SEROLOGY ToRCH lgM 2022 POSITIVE CONTROLI Intended for use with in vitro assays for determination of IgM antibodies to Cytomegalovirus (CMV), IgM antibodies to Rubella Virus, IgM antibodies to Toxoplasma gondii, IgM antibodies to Herpes Simplex Virus Type 1 and 2. Catalog Number: SR10349 recalled?

Yes. FDA published recall Z-0624-2024 on January 10, 2024. Reported hazard: A decrease in the reactivity of HSV Type 1/2 lgM in the Serology ToRCH lgM Positive Control when tested on the DiaSorin Liaison XL.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail